Lineage Cell Therapeutics... (LCTX)
AMEX: LCTX
· Real-Time Price · USD
1.19
0.17 (16.67%)
At close: Aug 15, 2025, 3:59 PM
1.21
1.68%
After-hours: Aug 15, 2025, 04:11 PM EDT
Lineage Cell Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.77M | 1.5M | 2.87M | 3.78M | 1.41M | 1.44M | 2.09M | 1.25M | 3.23M | 2.39M | 1.92M | 3M | 4.55M | 5.24M | 960K | 2.2M | 441K | 293K |
Cost of Revenue | 39K | 36K | 154K | 38K | 44K | 273K | 431K | 169K | 127K | 119K | 102K | 235K | 215K | 176K | 204K | 985K | 125K | 112K |
Gross Profit | 2.73M | 1.47M | 2.71M | 3.74M | 1.36M | 1.17M | 1.66M | 1.08M | 3.1M | 2.27M | 1.81M | 2.76M | 4.34M | 5.06M | 756K | 1.22M | 316K | 181K |
Operating Income | -19.78M | -6.5M | -5.11M | -3.84M | -5.87M | -6.66M | -6.36M | -6.71M | -5.02M | -6.64M | -6.64M | -5.25M | -4.23M | -6.4M | -28.24M | -6.84M | -7.08M | -7.05M |
Interest Income | 454K | 478K | 393K | 397K | 463K | 462K | 404K | 433K | 382K | 410K | 828K | 384K | 51K | 1K | 3K | n/a | n/a | 2K |
Pretax Income | -30.36M | -4.14M | -3.25M | -3M | -5.77M | -6.56M | -4.71M | -7.16M | -5.2M | -6.21M | -6.36M | -5.58M | -6.78M | -7.09M | -28.01M | -8.85M | -4.96M | -1.45M |
Net Income | -30.46M | -4.14M | -3.27M | -3.03M | -5.76M | -6.54M | -4.78M | -7.11M | -5.23M | -4.4M | -6.59M | -6.12M | -9.97M | -8.3M | -28.99M | -7.82M | -4.79M | -1.42M |
Selling & General & Admin | 4.56M | 4.86M | 4.4M | 4.41M | 4.36M | 4.84M | 4.14M | 4.04M | 4.25M | 4.72M | 4.35M | 4.42M | 5.27M | 8.47M | 4.42M | 5.32M | 4.54M | 3.94M |
Research & Development | 3.11M | 3.11M | 3.42M | 3.17M | 2.87M | 2.99M | 3.87M | 3.74M | 3.87M | 4.18M | 4.1M | 3.59M | 3.3M | 2.99M | 24.78M | 2.81M | 2.93M | 3.39M |
Other Expenses | 14.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.68M |
Operating Expenses | 22.51M | 7.97M | 7.82M | 7.58M | 7.23M | 7.83M | 8.02M | 7.78M | 8.12M | 8.91M | 8.45M | 8.01M | 8.57M | 11.46M | 28.99M | 8.06M | 7.4M | 7.23M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3K | 1K | 3K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -153K | -143K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 22.55M | 8.01M | 7.98M | 7.62M | 7.28M | 8.11M | 8.45M | 7.95M | 8.25M | 9.03M | 8.55M | 8.25M | 8.79M | 11.63M | 29.2M | 9.04M | 7.52M | 7.34M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -16K | n/a | n/a | n/a | -1.8M | 230K | 541K | 3.19M | 1.2M | 1.18M | -1.01M | -169K | n/a |
Shares Outstanding (Basic) | 228.36M | 226.05M | 200.19M | 188.84M | 188.81M | 182.91M | 172.66M | 174.87M | 170.59M | 170.13M | 170.01M | 169.79M | 169.07M | 169.65M | 167.62M | 167.62M | 159.6M | 158.72M |
Shares Outstanding (Diluted) | 228.36M | 226.05M | 200.19M | 188.84M | 188.81M | 182.91M | 172.66M | 174.87M | 170.59M | 170.13M | 170.01M | 169.79M | 169.73M | 169.65M | 167.62M | 167.62M | 162.91M | 158.72M |
EPS (Basic) | -0.13 | -0.02 | -0.02 | -0.02 | -0.03 | -0.04 | -0.03 | -0.04 | -0.03 | -0.03 | -0.04 | -0.04 | -0.06 | -0.05 | -0.17 | -0.05 | -0.03 | -0.01 |
EPS (Diluted) | -0.13 | -0.02 | -0.02 | -0.02 | -0.03 | -0.04 | -0.03 | -0.04 | -0.03 | -0.03 | -0.04 | -0.04 | -0.06 | -0.05 | -0.17 | -0.05 | -0.03 | -0.01 |
EBITDA | -4.77M | -6.5M | -4.96M | -3.7M | -5.72M | -6.49M | -6.19M | -6.53M | -4.85M | -6.47M | -6.47M | -5.06M | -4.05M | -6.22M | -27.82M | -6.64M | -6.88M | -6.76M |
EBIT | -4.94M | -6.5M | -5.11M | -3.84M | -5.87M | -6.66M | -6.36M | -6.71M | -5.02M | -6.64M | -6.64M | -5.25M | -4.23M | -6.4M | -28.24M | -6.84M | -7.08M | -7.05M |
Depreciation & Amortization | 171K | 164K | 151K | 141K | 142K | 175K | 175K | 176K | 170K | 171K | 188K | 178K | 178K | 178K | 186K | 199K | 208K | 296K |